Sinequan 10mg Capsules

Manufacturer PFIZER Active Ingredient Doxepin Capsules(DOKS e pin) Pronunciation DOKS-e-pin
WARNING: Drugs like this one have raised the chance of suicidal thoughts or actions in children and young adults. The risk may be greater in people who have had these thoughts or actions in the past. All people who take this drug need to be watched closely. Call the doctor right away if signs like depression, nervousness, restlessness, grouchiness, panic attacks, or changes in mood or actions are new or worse. Call the doctor right away if any thoughts or actions of suicide occur.This drug is not approved for use in children. Talk with the doctor. @ COMMON USES: It is used to treat depression.It is used to treat anxiety.It may be given to you for other reasons. Talk with the doctor.
đŸˇī¸
Drug Class
Antidepressant, Anxiolytic, Hypnotic
đŸ§Ŧ
Pharmacologic Class
Tricyclic Antidepressant (TCA), Serotonin-Norepinephrine Reuptake Inhibitor (SNRI), H1-receptor antagonist
🤰
Pregnancy Category
Category C
✅
FDA Approved
Mar 1969
âš–ī¸
DEA Schedule
Not Controlled

Overview

â„šī¸

What is this medicine?

Doxepin is a medication used to treat depression and anxiety. At lower doses, it's also used to help people with insomnia (trouble sleeping). It works by affecting certain natural chemicals in the brain that help regulate mood and sleep. Because it can make you very sleepy, especially at higher doses, it's often taken at bedtime.
📋

How to Use This Medicine

Taking Your Medication Correctly

To get the most benefit from your medication, take it exactly as directed by your doctor. Carefully read all the information provided with your prescription, and follow the instructions closely. If you are taking this medication once a day, it is best to take it at bedtime. Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start to feel well.

Storing and Disposing of Your Medication

To maintain the effectiveness and safety of your medication, store it at room temperature, protected from light, and in a dry place. Avoid storing it in a bathroom. Keep all medications in a secure location, out of the reach of children and pets. When your medication is no longer needed or has expired, dispose of it properly. Do not flush it down the toilet or pour it down the drain unless instructed to do so by your pharmacist or healthcare provider. If you have questions about the best way to dispose of your medication, consult with your pharmacist, who can also inform you about any drug take-back programs available in your area.

What to Do If You Miss a Dose

If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next scheduled dose, skip the missed dose and resume your regular dosing schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
💡

Lifestyle & Tips

  • Avoid alcohol and other CNS depressants (e.g., sedatives, tranquilizers) as they can increase drowsiness and other side effects.
  • Be cautious when driving or operating machinery until you know how this medication affects you, especially at the start of treatment or after a dose increase.
  • To minimize dizziness or lightheadedness when standing up, rise slowly from a sitting or lying position.
  • Manage dry mouth by drinking plenty of water, chewing sugar-free gum, or using saliva substitutes.
  • Increase fiber and fluid intake to help prevent constipation.
  • Regular exercise and a balanced diet can support overall well-being during treatment.

Dosing & Administration

đŸ‘¨â€âš•ī¸

Adult Dosing

Standard Dose: Depression/Anxiety: Initial 25-50 mg/day, typically at bedtime or in divided doses. Insomnia (low-dose): 3-6 mg once daily at bedtime.
Dose Range: 3 - 300 mg

Condition-Specific Dosing:

Depression and Anxiety (moderate to severe): Initial 50-75 mg/day, maximum 300 mg/day. Doses >150 mg/day may be given in divided doses.
Insomnia (low-dose): 3 mg or 6 mg once daily at bedtime, taken within 30 minutes of going to bed.
đŸ‘ļ

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Not established for depression/anxiety. Low-dose for insomnia not FDA approved for pediatric use.
Adolescent: Not established for depression/anxiety. Use generally not recommended due to suicidality risk. Low-dose for insomnia not FDA approved for pediatric use.
âš•ī¸

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended, but use with caution.
Moderate: No specific dose adjustment recommended, but use with caution.
Severe: No specific dose adjustment recommended, but use with caution. Monitor for adverse effects.
Dialysis: Not well studied. Use with caution and monitor for adverse effects.

Hepatic Impairment:

Mild: Consider lower initial doses and slower titration.
Moderate: Significant dose reduction may be necessary. Monitor plasma levels if available.
Severe: Contraindicated or not recommended due to extensive hepatic metabolism. If used, extreme caution and significant dose reduction required.

Pharmacology

đŸ”Ŧ

Mechanism of Action

Doxepin is a tricyclic antidepressant (TCA) that primarily inhibits the reuptake of norepinephrine (NE) and serotonin (5-HT) at presynaptic neuronal membranes, thereby increasing the concentration of these neurotransmitters in the synaptic cleft. It also possesses significant antagonistic activity at histamine H1, muscarinic cholinergic, and alpha-1 adrenergic receptors, contributing to its sedative, anticholinergic, and orthostatic hypotensive effects, respectively. At low doses (3-6 mg), its primary mechanism for insomnia is potent H1 receptor antagonism.
📊

Pharmacokinetics

Absorption:

Bioavailability: Variable, approximately 13-45% due to extensive first-pass metabolism.
Tmax: 2-4 hours (oral capsule).
FoodEffect: Food can delay Tmax but does not significantly affect AUC.

Distribution:

Vd: 9-33 L/kg (large volume of distribution).
ProteinBinding: Approximately 80-85% (primarily to albumin).
CnssPenetration: Yes

Elimination:

HalfLife: Doxepin: 10-25 hours; Desmethyldoxepin: 28-51 hours.
Clearance: Not precisely quantified, but extensive hepatic metabolism.
ExcretionRoute: Renal (primarily as metabolites).
Unchanged: <3% (doxepin) and <6% (desmethyldoxepin) excreted unchanged in urine.
âąī¸

Pharmacodynamics

OnsetOfAction: Sedative effects: within 30-60 minutes. Antidepressant effects: 2-4 weeks.
PeakEffect: Sedative effects: 2-4 hours. Antidepressant effects: 4-6 weeks.
DurationOfAction: Sedative effects: 6-8 hours (low dose for insomnia). Antidepressant effects: 24 hours (due to long half-life).

Safety & Warnings

âš ī¸

BLACK BOX WARNING

Antidepressants increased the risk compared to placebo of suicidal thinking and behavior (suicidality) in children, adolescents, and young adults in short-term studies of Major Depressive Disorder (MDD) and other psychiatric disorders. Anyone considering the use of doxepin or any other antidepressant in a child, adolescent, or young adult must balance this risk with the clinical need. Short-term studies did not show an increase in the risk of suicidality with antidepressants compared to placebo in adults beyond age 24; there was a reduction in risk with antidepressants compared to placebo in adults aged 65 and older. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide. Patients of all ages who are started on antidepressant therapy should be monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior. Families and caregivers should be advised of the need for close observation and communication with the prescriber.
âš ī¸

Side Effects

Urgent Side Effects: Seek Medical Help Right Away

While rare, some people may experience severe and potentially life-threatening side effects when taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high or low blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Fast heartbeat
Difficulty urinating
Feeling extremely nervous or excitable
Fever, chills, or sore throat
Unexplained bruising or bleeding
Feeling very tired or weak
Yellowing of the skin or eyes (jaundice)
Ringing in the ears (tinnitus)
Changes in sex interest
Enlarged breasts or nipple discharge
Swelling of the testicles

Important Warning for People with Asthma

If you have asthma, use this medication with caution. Worsening of asthma has been reported in people taking this medication. If your asthma symptoms worsen while taking this medication, contact your doctor right away.

Other Possible Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. If you notice any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor or seek medical attention:

Feeling dizzy, sleepy, tired, or weak
Constipation, diarrhea, stomach pain, upset stomach, vomiting, or decreased appetite
Dry mouth
Changes in taste
Mouth irritation or mouth sores
Weight gain
Excessive sweating
Flushing
Hair loss
* Headache

Reporting Side Effects

This is not a comprehensive list of all possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Worsening depression or suicidal thoughts/behavior (especially in young adults)
  • New or worsening anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (restlessness), hypomania, or mania
  • Severe dizziness or fainting spells
  • Fast, pounding, or irregular heartbeat
  • Difficulty urinating or inability to urinate
  • Severe constipation or abdominal pain
  • Blurred vision or eye pain
  • Unexplained fever, sore throat, or other signs of infection (may indicate blood problems)
  • Yellowing of skin or eyes (jaundice)
  • Seizures
  • Rash or hives
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including any symptoms.
Certain health conditions, including:
+ Difficulty urinating
+ Glaucoma
Current or recent use of specific medications, such as:
+ Linezolid
+ Methylene blue
+ Certain antidepressants or Parkinson's disease medications taken within the last 14 days, including:
- Isocarboxazid
- Phenelzine
- Tranylcypromine
- Selegiline
- Rasagiline (note: taking these medications with this drug can lead to very high blood pressure)
Use of other medications that can cause drowsiness, as combining them with this medication may increase the risk of excessive sleepiness. If you are unsure, consult your doctor or pharmacist.
If you are breastfeeding, as you should not breastfeed while taking this medication.

This list is not exhaustive, and it is crucial to inform your doctor and pharmacist about all your medications, including:

Prescription and over-the-counter (OTC) medications
Natural products
Vitamins

Your doctor needs to be aware of all your medications and health conditions to ensure it is safe for you to take this medication. Do not start, stop, or change the dose of any medication without consulting your doctor first.
âš ī¸

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Before engaging in activities that require alertness, such as driving, wait until you understand how this drug affects you.

Please note that it may take several weeks to experience the full effects of this medication. Do not abruptly stop taking this drug without consulting your doctor, as this may increase your risk of side effects. If you need to discontinue this medication, your doctor will instruct you on how to gradually stop taking it to minimize potential side effects.

While taking this medication, it is recommended that you avoid consuming alcohol. Additionally, consult with your doctor before using marijuana, cannabis, or any prescription or over-the-counter medications that may cause drowsiness or impair your reactions.

Some individuals may be at a higher risk of developing eye problems while taking this medication. Your doctor may recommend an eye exam to assess your risk. If you experience eye pain, changes in vision, or swelling and redness in or around the eye, contact your doctor immediately.

This medication may increase your sensitivity to the sun, making you more prone to sunburn. Take necessary precautions when exposed to sunlight, and inform your doctor if you experience excessive sunburning while taking this medication.

If you have diabetes, it is crucial to closely monitor your blood sugar levels. Be aware of signs of high or low blood sugar, such as fruity breath odor, dizziness, rapid breathing, rapid heartbeat, confusion, drowsiness, weakness, flushing, headache, unusual thirst or hunger, frequent urination, shaking, or sweating. Report any of these symptoms to your doctor.

If you are 65 years or older, use this medication with caution, as you may be more susceptible to side effects.

Certain medications, including this one, may affect fertility and impact your ability to have children. If you have concerns or questions, discuss them with your doctor.

If you are pregnant or planning to become pregnant, consult with your doctor to weigh the benefits and risks of taking this medication during pregnancy. Taking this drug in the third trimester may lead to health problems in the newborn, so it is essential to discuss this with your doctor.
🆘

Overdose Information

Overdose Symptoms:

  • Severe drowsiness or coma
  • Confusion or disorientation
  • Severe dry mouth
  • Blurred vision
  • Dilated pupils
  • Fast or irregular heartbeat (tachycardia)
  • Low blood pressure (hypotension)
  • Urinary retention
  • Constipation
  • Respiratory depression
  • Seizures
  • Cardiac arrhythmias (e.g., QT prolongation, ventricular fibrillation)
  • Hypothermia

What to Do:

Seek immediate medical attention. Call 911 or Poison Control at 1-800-222-1222. Treatment is supportive and symptomatic, including gastric lavage, activated charcoal, maintaining airway, monitoring cardiac function, and managing seizures or arrhythmias.

Drug Interactions

đŸšĢ

Contraindicated Interactions

  • Monoamine Oxidase Inhibitors (MAOIs) - risk of hyperpyretic crisis, severe convulsions, and death.
  • Cisapride - risk of QT prolongation and arrhythmias.
  • Pimozide - risk of QT prolongation and arrhythmias.
🔴

Major Interactions

  • CNS Depressants (e.g., alcohol, benzodiazepines, opioids, sedatives, hypnotics) - additive CNS depression.
  • Anticholinergic agents (e.g., atropine, benztropine, diphenhydramine) - additive anticholinergic effects (e.g., severe constipation, urinary retention, blurred vision, delirium).
  • Adrenergic neuron blocking agents (e.g., guanethidine, clonidine) - may block antihypertensive effects.
  • CYP2D6 inhibitors (e.g., fluoxetine, paroxetine, quinidine) - increased doxepin plasma levels.
  • Thyroid hormones - increased risk of cardiac arrhythmias.
  • Cimetidine - increased doxepin plasma levels.
  • Sympathomimetics (e.g., epinephrine, norepinephrine) - enhanced pressor response.
🟡

Moderate Interactions

  • Anticoagulants (e.g., warfarin) - potential for increased anticoagulant effect (monitor INR).
  • Barbiturates - may decrease doxepin plasma levels.
  • Phenytoin - altered phenytoin levels.
  • Oral contraceptives - may increase doxepin plasma levels.
đŸŸĸ

Minor Interactions

  • Not available

Monitoring

đŸ”Ŧ

Baseline Monitoring

Complete Blood Count (CBC) with differential

Rationale: To establish baseline and monitor for blood dyscrasias (e.g., agranulocytosis, thrombocytopenia) which are rare but serious side effects of TCAs.

Timing: Prior to initiation of therapy.

Liver Function Tests (LFTs)

Rationale: To establish baseline and monitor for hepatic impairment, as doxepin is extensively metabolized by the liver.

Timing: Prior to initiation of therapy.

Electrocardiogram (ECG)

Rationale: To assess cardiac conduction, especially in patients with pre-existing cardiac disease or elderly patients, due to potential for QT prolongation and other arrhythmias.

Timing: Prior to initiation of therapy, especially in patients >40 years old or with cardiac risk factors.

Blood Pressure and Heart Rate

Rationale: To establish baseline and monitor for orthostatic hypotension and tachycardia.

Timing: Prior to initiation of therapy (supine and standing).

Mental Status Examination/Suicidality Risk Assessment

Rationale: To establish baseline mood, thought content, and assess for suicidal ideation, especially in young adults and adolescents.

Timing: Prior to initiation of therapy.

📊

Routine Monitoring

Mental Status Examination/Suicidality Risk Assessment

Frequency: Weekly during initial weeks of therapy and dose changes, then periodically.

Target: Improvement in target symptoms without emergence or worsening of suicidal ideation.

Action Threshold: Any new or worsening suicidal ideation, agitation, or unusual changes in behavior require immediate clinical assessment and intervention.

Blood Pressure and Heart Rate

Frequency: Regularly during dose titration and periodically thereafter.

Target: Within patient's normal range, without significant orthostatic drops.

Action Threshold: Symptomatic orthostatic hypotension or sustained tachycardia.

Anticholinergic Side Effects (e.g., dry mouth, constipation, urinary retention, blurred vision)

Frequency: Regularly, especially during dose titration.

Target: Minimal or manageable side effects.

Action Threshold: Severe or unmanageable anticholinergic symptoms requiring dose reduction or discontinuation.

Sedation/Drowsiness

Frequency: Regularly, especially during initial therapy.

Target: Acceptable level of sedation, particularly if used for insomnia.

Action Threshold: Excessive sedation impairing daily activities or increasing fall risk.

Therapeutic Drug Monitoring (TDM) - Doxepin and Nordoxepin levels

Frequency: Consider for non-responders, patients with severe side effects, or suspected non-adherence. Not routinely recommended for low-dose insomnia.

Target: Doxepin + Nordoxepin: 100-250 ng/mL (for depression/anxiety).

Action Threshold: Levels outside therapeutic range, correlating with clinical response or toxicity.

đŸ‘ī¸

Symptom Monitoring

  • Worsening depression
  • Suicidal thoughts or behavior
  • Unusual changes in behavior (e.g., agitation, irritability, aggression, panic attacks, insomnia, impulsivity, hypomania, mania)
  • Orthostatic dizziness or lightheadedness
  • Dry mouth
  • Constipation
  • Urinary retention
  • Blurred vision
  • Excessive sedation or drowsiness
  • Confusion or disorientation (especially in elderly)
  • Tremor
  • Seizures
  • Skin rash
  • Sore throat, fever, or other signs of infection (potential blood dyscrasias)
  • Yellowing of skin or eyes, dark urine (potential liver issues)

Special Patient Groups

🤰

Pregnancy

Category C. Doxepin should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies in pregnant women. Neonates exposed to TCAs in the third trimester have developed withdrawal symptoms (e.g., respiratory distress, feeding difficulties, irritability, tremor, hypertonia, hypotonia, seizures).

Trimester-Specific Risks:

First Trimester: Limited data, but generally considered low risk for major malformations based on TCA class data. However, animal studies show some adverse effects.
Second Trimester: Potential for fetal exposure and accumulation. Monitor for fetal growth and well-being.
Third Trimester: Risk of neonatal withdrawal symptoms and persistent pulmonary hypertension of the newborn (PPHN) if exposed close to delivery. Monitor neonate closely.
🤱

Lactation

L3 (Moderately Safe). Doxepin and its active metabolite (desmethyldoxepin) are excreted into breast milk. While levels are generally low, sedation, poor feeding, and weight gain have been reported in some infants. Use with caution, monitor infant for drowsiness, feeding difficulties, and developmental milestones. Consider alternative agents with better safety profiles if possible, especially in preterm or neonates.

Infant Risk: Low to moderate risk. Monitor for sedation, poor feeding, and weight gain.
đŸ‘ļ

Pediatric Use

Not FDA approved for depression or anxiety in pediatric patients due to increased risk of suicidality (Black Box Warning). Low-dose doxepin for insomnia is not FDA approved for pediatric use. Use in children and adolescents should be approached with extreme caution and only after careful consideration of risks vs. benefits, with close monitoring.

👴

Geriatric Use

Elderly patients are more sensitive to the anticholinergic, sedative, and orthostatic hypotensive effects of doxepin. Start with lower doses (e.g., 10-25 mg/day for depression/anxiety, 3 mg for insomnia) and titrate slowly. Doxepin is on the Beers Criteria list for potentially inappropriate medication use in older adults due to its strong anticholinergic properties and risk of orthostatic hypotension and sedation. Monitor closely for falls, cognitive impairment, and urinary retention.

Clinical Information

💎

Clinical Pearls

  • Doxepin is one of the most sedating TCAs due to its potent H1 receptor antagonism, making it particularly useful for depression with prominent insomnia or for primary insomnia at low doses.
  • The low-dose formulation (Silenor) for insomnia is specifically designed to target H1 receptors for sleep promotion with minimal antidepressant effects.
  • Due to its anticholinergic properties, doxepin can cause significant dry mouth, constipation, and urinary retention, especially at higher doses. These effects can be particularly problematic in the elderly.
  • Orthostatic hypotension is a common side effect, especially at the start of therapy or with dose increases, increasing the risk of falls.
  • Withdrawal symptoms (e.g., nausea, headache, malaise, vivid dreams, irritability) can occur if discontinued abruptly, especially after prolonged use. Taper dose gradually.
  • Therapeutic drug monitoring (TDM) for doxepin and nordoxepin levels can be useful in cases of non-response, suspected toxicity, or drug interactions, though not routinely performed for low-dose insomnia.
🔄

Alternative Therapies

  • Other Tricyclic Antidepressants (TCAs): Amitriptyline, Imipramine, Nortriptyline
  • Selective Serotonin Reuptake Inhibitors (SSRIs): Fluoxetine, Sertraline, Paroxetine, Citalopram, Escitalopram
  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs): Venlafaxine, Duloxetine
  • Atypical Antidepressants: Bupropion, Mirtazapine, Trazodone
  • For Insomnia: Zolpidem, Eszopiclone, Zaleplon (Z-drugs), Ramelteon, Suvorexant, Lemborexant, Trazodone, Mirtazapine, Cognitive Behavioral Therapy for Insomnia (CBT-I)
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 30 capsules (10mg generic)
Generic Available: Yes
Insurance Coverage: Tier 1 or Tier 2 (Generic), Tier 3 or Non-Formulary (Brand)
📚

General Drug Facts

If your symptoms or health issues persist or worsen, it is essential to contact your doctor promptly. To ensure safe use, never share your medication with others, and do not take medication prescribed to someone else. This medication is accompanied by a Medication Guide, which is a crucial resource for patients. Please read this guide carefully and review it again whenever you receive a refill of this medication. If you have any questions or concerns about this medication, consult with your doctor, pharmacist, or other healthcare provider. In the event of a suspected overdose, immediately call the poison control center or seek emergency medical attention. When reporting the incident, be prepared to provide detailed information, including the substance taken, the quantity, and the time it occurred.